Polymorphisms in MSH2 gene and risk of gastric cancer, and interactions with lifestyle factors in a Chinese population

Cancer Epidemiology

Volumn 36, Issue 3, 2012, Pages

  Wang, Deqiang ^a   Zhou, Jiannon ^b   Wang, Tingting ^b   Li, Xiaoqin ^a   Li, Suping ^b   Chen, Senqing ^b   Ma, Guojian ^b   Li, Jintian ^b   Zhang, Xiaomei ^b  

^a AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

^b JIANGSU CANCER HOSPITAL   (China)

Author keywords

Gastric cancer; MSH2 gene; Single nucleotide polymorphisms

Indexed keywords

PROTEIN MSH2;

ADULT; AGE; ALLELE; ARTICLE; CANCER RISK; CHINA; CONTROLLED STUDY; FEMALE; FOOD INTAKE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER;

AGE FACTORS; AGED; ALCOHOL DRINKING; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; FOOD HABITS; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; STOMACH NEOPLASMS;

EID: 84862807840     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2012.02.003     Document Type: Article

References (47)

1. Parkin D.M., Pisani P., Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999, 80:827-841.
2. Sheng J., Shen Z., Fan C. Clinical phenotypes of hereditary nonpolyposis colorectal cancer in Chinese population. Zhonghua Yi Xue Za Zhi 2002, 82:1371-1374.
3. Yuan Y., Ye J., Zheng S. Clinical and genetic features of International Collaborative Group-hereditary nonpolyposis colorectal cancer families and suspected hereditary nonpolyposis colorectal cancer families. Chin Med J (Engl) 2004, 117:748-752.
4. Peltomaki P. Lynch syndrome genes. Fam Cancer 2005, 4:227-232.
5. Li G.M. Mechanisms and functions of DNA mismatch repair. Cell Res 2008, 18:85-98.
6. Yanagisawa Y., Akiyama Y., Iida S., Ito E., Nomizu T., Sugihara K., et al. Methylation of the hMLH1 promoter in familial gastric cancer with microsatellite instability. Int J Cancer 2000, 85:50-53.
7. Zhang Y., Liu X., Fan Y., Ding J., Xu A., Zhou X., et al. Germline mutations and polymorphic variants in MMR, E-cadherin and MYH genes associated with familial gastric cancer in Jiangsu of China. Int J Cancer 2006, 119:2592-2596.
8. Shin K.H., Shin J.H., Kim J.H., Park J.G. Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene. Cancer Res 2002, 62:38-42.
9. Beiner M.E., Rosen B., Fyles A., Harley I., Pal T., Siminovitch K., et al. Endometrial cancer risk is associated with variants of the mismatch repair genes MLH1 and MSH2. Cancer Epidemiol Biomarkers Prev 2006, 15:1636-1640.
10. Brentnall T.A., Rubin C.E., Crispin D.A., Stevens A., Batchelor R.H., Haggitt R.C., et al. A germline substitution in the human MSH2 gene is associated with high-grade dysplasia and cancer in ulcerative colitis. Gastroenterology 1995, 109:151-155.
11. De Vivo I., Huggins G.S., Hankinson S.E., Lescault P.J., Boezen M., Colditz G.A., et al. A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk. Proc Natl Acad Sci U S A 2002, 99:12263-12268.
12. Goessl C., Plaschke J., Pistorius S., Hahn M., Frank S., Hampl M., et al. An intronic germline transition in the HNPCC gene hMSH2 is associated with sporadic colorectal cancer. Eur J Cancer 1997, 33:1869-1874.
13. Jung C.Y., Choi J.E., Park J.M., Chae M.H., Kang H.G., Kim K.M., et al. Polymorphisms in the hMSH2 gene and the risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 2006, 15:762-768.
14. Palicio M., Blanco I., Tortola S., Gonzalez I., Marcuello E., Brunet J., et al. Intron splice acceptor site polymorphism in the hMSH2 gene in sporadic and familial colorectal cancer. Br J Cancer 2000, 82:535-537.
15. Paz-y-Mino C., Perez J.C., Fiallo B.F., Leone P.E. A polymorphism in the hMSH2 gene (gIVS12-6T>C) associated with non-Hodgkin lymphomas. Cancer Genet Cytogenet 2002, 133:29-33.
16. Worrillow L.J., Travis L.B., Smith A.G., Rollinson S., Smith A.J., Wild C.P., et al. An intron splice acceptor polymorphism in hMSH2 and risk of leukemia after treatment with chemotherapeutic alkylating agents. Clin Cancer Res 2003, 9:3012-3020.
17. Auclair J., Busine M.P., Navarro C., Ruano E., Montmain G., Desseigne F., et al. Systematic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing. Hum Mutat 2006, 27:145-154.
18. Barnetson R.A., Cartwright N., van Vliet A., Haq N., Drew K., Farrington S., et al. Classification of ambiguous mutations in DNA mismatch repair genes identified in a population-based study of colorectal cancer. Hum Mutat 2008, 29:367-374.
19. Tournier I., Vezain M., Martins A., Charbonnier F., Baert-Desurmont S., Olschwang S., et al. A large fraction of unclassified variants of the mismatch repair genes MLH1 and MSH2 is associated with splicing defects. Hum Mutat 2008, 29:1412-1424.
20. Compare D., Rocco A., Nardone G. Risk factors in gastric cancer. Eur Rev Med Pharmacol Sci 2010, 14:302-308.
21. Phillips D.H. Smoking-related DNA and protein adducts in human tissues. Carcinogenesis 2002, 23:1979-2004.
22. Jagerstad M., Skog K. Genotoxicity of heat-processed foods. Mutat Res 2005, 574:156-172.
23. Wu D., Zhai Q., Shi X. Alcohol-induced oxidative stress and cell responses. J Gastroenterol Hepatol 2006, 21(Suppl. 3):S26-S29.
24. Vincent H.K., Innes K.E., Vincent K.R. Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity. Diabetes Obes Metab 2007, 9:813-839.
25. Gao C., Takezaki T., Wu J., Li Z., Wang J., Ding J., et al. Interaction between cytochrome P-450 2E1 polymorphisms and environmental factors with risk of esophageal and stomach cancers in Chinese. Cancer Epidemiol Biomarkers Prev 2002, 11:29-34.
26. Oliveira C., Seruca R., Carneiro F. Genetics, pathology, and clinics of familial gastric cancer. Int J Surg Pathol 2006, 14:21-33.
27. Gross E., Arnold N., Goette J., Schwarz-Boeger U., Kiechle M. A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC. Hum Genet 1999, 105:72-78.
28. Hsu H.S., Lee I.H., Hsu W.H., Kao W.T., Wang Y.C. Polymorphism in the hMSH2 gene (gISV12-6T>C) is a prognostic factor in non-small cell lung cancer. Lung Cancer 2007, 58:123-130.
29. Kim J.G., Chae Y.S., Sohn S.K., Moon J.H., Kang B.W., Park J.Y., et al. IVS10+12A>G polymorphism in hMSH2 gene associated with prognosis for patients with colorectal cancer. Ann Oncol 2010, 21:525-529.
30. Wu J., Wang D., Song L., Li S., Ding J., Chen S., et al. A new familial gastric cancer-related gene polymorphism: T1151A in the mismatch repair gene hMLH1. Mol Biol Rep 2011, 38:3181-3187.
31. Hsu H.S., Wen C.K., Tang Y.A., Lin R.K., Li W.Y., Hsu W.H., et al. Promoter hypermethylation is the predominant mechanism in hMLH1 and hMSH2 deregulation and is a poor prognostic factor in nonsmoking lung cancer. Clin Cancer Res 2005, 11:5410-5416.
32. Wang Y.C., Lu Y.P., Tseng R.C., Lin R.K., Chang J.W., Chen J.T., et al. Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples. J Clin Invest 2003, 111:887-895.
33. Chung D.C., Rustgi A.K. The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications. Ann Intern Med 2003, 138:560-570.
34. Lynch H.T., Smyrk T. Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review. Cancer 1996, 78:1149-1167.
35. Campbell P.T., Curtin K., Ulrich C.M., Samowitz W.S., Bigler J., Velicer C.M., et al. Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factors. Gut 2009, 58:661-667.
36. Pande M., Lynch P.M., Hopper J.L., Jenkins M.A., Gallinger S., Haile R.W., et al. Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center. Clin Cancer Res 2010, 16(4):1331-1339.
37. Willett W. Nutritional epidemiology 1998, Oxford University Press, New York, NY. 2nd ed.
38. Jakszyn P., Gonzalez C.A. Nitrosamine and related food intake and gastric and oesophageal cancer risk: a systematic review of the epidemiological evidence. World J Gastroenterol 2006, 12:4296-4303.
39. Zhang Y.W., Eom S.Y., Kim Y.D., Song Y.J., Yun H.Y., Park J.S., et al. Effects of dietary factors and the NAT2 acetylator status on gastric cancer in Koreans. Int J Cancer 2009, 125:139-145.
40. Ngoan L.T., Mizoue T., Fujino Y., Tokui N., Yoshimura T. Dietary factors and stomach cancer mortality. Br J Cancer 2002, 87:37-42.
41. Wu A.H., Yang D., Pike M.C. A meta-analysis of soyfoods and risk of stomach cancer: the problem of potential confounders. Cancer Epidemiol Biomarkers Prev 2000, 9:1051-1058.
42. Campbell P.T., Sloan M., Kreiger N. Dietary patterns and risk of incident gastric adenocarcinoma. Am J Epidemiol 2008, 167:295-304.
43. Tsao J.L., Dudley S., Kwok B., Nickel A.E., Laird P.W., Siegmund K.D., et al. Diet, cancer and aging in DNA mismatch repair deficient mice. Carcinogenesis 2002, 23:1807-1810.
44. Wang Y., Friedl W., Lamberti C., Nothen M.M., Kruse R., Propping P. A novel missense mutation in the DNA mismatch repair gene hMLH1 present among East Asians but not among Europeans. Hum Hered 1998, 48:87-91.
45. Fan Y., Liu X., Zhang H., Dai J., Zhang X., Zhu M., et al. Variations in exon 7 of the MSH2 gene and susceptibility to gastrointestinal cancer in a Chinese population. Cancer Genet Cytogenet 2006, 170(2):121-128.
46. Wang Y., Friedl W., Propping P., Li J., Li Z., Wang J. Val384Asp in hMLH1 gene in Chinese, Japanese and German and its etiological role in colorectal cancer. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 1998, 15:263-266.
47. Ioannidis J.P.A. Meta-analysis in public health: potential and problems. Ital J Public Health 2006, 3:9-14.